Literature DB >> 10377307

Abnormalities in liver function and coagulation profile following the Fontan procedure.

R C van Nieuwenhuizen1, M Peters, L J Lubbers, M D Trip, J G Tijssen, B J Mulder.   

Abstract

OBJECTIVE: To investigate liver function and coagulation disorders in patients with a Fontan circulation at different time intervals after surgery.
DESIGN: Retrospective analysis of clinical data and cross sectional study relating liver function and coagulation profile to time since surgery, in 28 surviving patients after the modified Fontan procedure. PATIENTS: 20 patients (71%) with atriopulmonary anastomosis, seven (25%) with atrioventricular anastomosis, and one (4%) with total cavopulmonary connection. Follow up ranged from 2.0 to 21.8 years (mean 11.1).
RESULTS: Abnormal liver function tests, mainly reflecting cholestasis, were present in 21 patients who had a significantly longer follow up (p < 0.01). Protein synthesis was normal in almost all patients. Coagulation profile showed abnormalities in 22 patients. "Procoagulant" abnormalities-that is, decreased plasminogen and protein C activity-were found in 11 and five patients, respectively. The extent of these abnormalities was less in patients with a longer follow up. Anticoagulant abnormalities were factor V deficiency in 16 patients and factor VII deficiency in 17, resulting in a prolonged prothrombin time in 19 patients. Thirteen patients had both pro- and anticoagulant abnormalities. A prethrombotic state was present in five patients, with a significantly longer mean time interval since surgery (p = 0.05). Thus, although the individual procoagulant indices decreased with increasing time intervals since surgery, a prethrombotic state was found particularly in patients with a long term follow up.
CONCLUSIONS: Mild cholestasis was mainly present in Fontan patients with a long duration of follow up. Along with laboratory procoagulant abnormalities indicating a prethrombotic state, anticoagulant abnormalities were also present. The coagulation profile varied at different time intervals after surgery. Thus detailed evaluation should be performed regularly, and the use of anticoagulants should be considered in every patient. Long term prospective studies are needed to evaluate the individual fluctuations of coagulation profile over time following a Fontan procedure.

Entities:  

Mesh:

Year:  1999        PMID: 10377307      PMCID: PMC1729092          DOI: 10.1136/hrt.82.1.40

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  26 in total

1.  Five- to fifteen-year follow-up after Fontan operation.

Authors:  D J Driscoll; K P Offord; R H Feldt; H V Schaff; F J Puga; G K Danielson
Journal:  Circulation       Date:  1992-02       Impact factor: 29.690

2.  The Fontan procedure: lessons from the past.

Authors:  K Bull
Journal:  Heart       Date:  1998-03       Impact factor: 5.994

3.  Protein C activity and antigen levels in childhood.

Authors:  A van Teunenbroek; M Peters; A Sturk; J J Borm; C Breederveld
Journal:  Eur J Pediatr       Date:  1990-08       Impact factor: 3.183

4.  Liver fibrosis (cardiac cirrhosis) five years after modified Fontan operation for tricuspid atresia.

Authors:  J H Lemmer; A G Coran; D M Behrendt; K P Heidelberger; A M Stern
Journal:  J Thorac Cardiovasc Surg       Date:  1983-11       Impact factor: 5.209

5.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

Authors:  J A Hoek; A Sturk; J W ten Cate; R J Lamping; F Berends; J J Borm
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

6.  Cardiovascular status after repair by Fontan procedure.

Authors:  D M Behrendt; A Rosenthal
Journal:  Ann Thorac Surg       Date:  1980-04       Impact factor: 4.330

7.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors:  S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal:  J Am Coll Cardiol       Date:  1991-08       Impact factor: 24.094

8.  The significance of protein C antigen in acute and chronic liver biliary disease.

Authors:  S Viganó; P M Mannucci; A D'Angelo; M G Rumi; P Viganó; E Del Ninno; A Cargnel; M Colombo; M Podda
Journal:  Am J Clin Pathol       Date:  1985-10       Impact factor: 2.493

9.  Acute liver dysfunction after modified Fontan operation for complex cardiac lesions. Analysis of the contributing factors and its relation to the early prognosis.

Authors:  H Matsuda; E Covino; H Hirose; S Nakano; H Kishimoto; Y Miyamoto; K Nishigaki; H Takano; S Ohtake; S Sakaki
Journal:  J Thorac Cardiovasc Surg       Date:  1988-08       Impact factor: 5.209

10.  Long-term results after the Fontan operation for tricuspid atresia.

Authors:  D A Girod; F Fontan; C Deville; J Ottenkamp; A Choussat
Journal:  Circulation       Date:  1987-03       Impact factor: 29.690

View more
  22 in total

1.  Long-term survival of patients with single ventricle; which imaging modality?

Authors:  T Oosterhof; B J M Mulder
Journal:  Int J Cardiovasc Imaging       Date:  2004-06       Impact factor: 2.357

2.  Prophylactic anticoagulation following the Fontan operation.

Authors:  H A Walker; M A Gatzoulis
Journal:  Heart       Date:  2005-07       Impact factor: 5.994

Review 3.  [Intensive care management of critically ill adults with congenital heart disease].

Authors:  D Bettex; M Bosshart; P G Chassot; A Rudiger
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-08-29       Impact factor: 0.840

4.  A viable therapeutic option: mechanical circulatory support of the failing Fontan physiology.

Authors:  Amy L Throckmorton; Sergio Lopez-Isaza; Emily A Downs; Steven G Chopski; James J Gangemi; William Moskowitz
Journal:  Pediatr Cardiol       Date:  2013-02-15       Impact factor: 1.655

Review 5.  Congenital heart disease-associated liver disease: a narrative review.

Authors:  Florian P Reiter; Nino J Hadjamu; Nicole Nagdyman; Reinhart Zachoval; Julia Mayerle; Enrico N De Toni; Harald Kaemmerer; Gerald Denk
Journal:  Cardiovasc Diagn Ther       Date:  2021-04

6.  Prospective study of the incidence and predictors of thrombus in children undergoing palliative surgery for single ventricle physiology.

Authors:  Deanna R Todd Tzanetos; Chang Yu; Marta Hernanz-Schulman; Frederick E Barr; Nancy J Brown
Journal:  Intensive Care Med       Date:  2011-10-07       Impact factor: 17.440

7.  Hepatic Changes in the Fontan Circulation: Identification of Liver Dysfunction and an Attempt to Streamline Follow-up Screening.

Authors:  T Ackerman; A Geerts; H Van Vlierberghe; J De Backer; K François
Journal:  Pediatr Cardiol       Date:  2018-07-21       Impact factor: 1.655

8.  Risk factors and serological markers of liver cirrhosis after Fontan procedure.

Authors:  Mikiko Shimizu; Kenji Miyamoto; Yunosuke Nishihara; Gaku Izumi; Shuji Sakai; Kei Inai; Toshio Nishikawa; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2015-09-19       Impact factor: 2.037

9.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

10.  Altered Cholesterol Metabolism and Hypocholesterolemia in Patients with Single Ventricle following Fontan Palliation.

Authors:  Wendy Whiteside; Meng Tan; Richard E Ostlund; Sunkyung Yu; Lina Ma; Albert Rocchini
Journal:  J Pediatr       Date:  2016-01-21       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.